Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.50
Delayed Data
As of Aug 28
 +0.07 / +0.67%
Today’s Change
6.38
Today|||52-Week Range
13.84
-7.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues28.0M33.9M14.8M36.6M
 
 
 
 
 
Depreciation And Amortization570.0K412.0K1.1M1.0M
 
 
 
 
 
 
Operating ExpensesGross Income----13.8M--
 
 
General Expenses51.2M38.6M43.8M54.1M
 
 
 
 
 
Research And Development43.6M30.7M35.7M42.8M
 
 
 
 
 
Total Operating Expenses51.7M39.0M44.9M55.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.7M-5.1M-30.0M-18.6M
 
 
 
 
 
Interest Expense On Debt4.6M4.6M4.6M4.5M
 
 
 
 
 
Other Expenses265.0K151.0K113.0K110.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.0M-9.5M-34.4M-22.9M
 
 
 
 
 
Minority Interest-137.0K-219.0K-327.0K-123.0K
 
 
 
 
 
Net Income-27.9M-9.7M-34.8M-22.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS104.9M106.7M107.1M110.0M
 
 
 
 
 
Shares To Calculate EPS Diluted104.9M106.7M107.1M110.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.09-$0.32-$0.21
 
 
 
 
 
EPS Diluted-$0.27-$0.09-$0.32-$0.21